# Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.

> **NCT03436212** · NA · COMPLETED · sponsor: **Air Liquide Santé International** · enrollment: 24 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DEVICE:** Continuous Glucose Monitoring (CGM)

## Key facts

- **NCT ID:** NCT03436212
- **Lead sponsor:** Air Liquide Santé International
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-05
- **Primary completion:** 2018-03-06
- **Final completion:** 2018-03-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03436212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03436212, "Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03436212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*